Copyright Reports & Markets. All rights reserved.

Global Radiation Curable Formulation Market Research Report 2021

Request for Sample of this report
Buy now

1 Radiation Curable Formulation Market Overview

  • 1.1 Product Overview and Scope of Radiation Curable Formulation
  • 1.2 Radiation Curable Formulation Segment by Type
    • 1.2.1 Global Radiation Curable Formulation Market Size Growth Rate Analysis by Type 2021 VS 2027
    • 1.2.2 Ultraviolet (UV) Curing
    • 1.2.3 Electron beam (EB) Curing
  • 1.3 Radiation Curable Formulation Segment by Application
    • 1.3.1 Global Radiation Curable Formulation Consumption Comparison by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Coatings
    • 1.3.3 Inks
    • 1.3.4 Adhesives
    • 1.3.5 Electronics
  • 1.4 Global Market Growth Prospects
    • 1.4.1 Global Radiation Curable Formulation Revenue Estimates and Forecasts (2016-2027)
    • 1.4.2 Global Radiation Curable Formulation Production Capacity Estimates and Forecasts (2016-2027)
    • 1.4.3 Global Radiation Curable Formulation Production Estimates and Forecasts (2016-2027)
  • 1.5 Global Market Size by Region
    • 1.5.1 Global Radiation Curable Formulation Market Size Estimates and Forecasts by Region: 2016 VS 2021 VS 2027
    • 1.5.2 North America Radiation Curable Formulation Estimates and Forecasts (2016-2027)
    • 1.5.3 Europe Radiation Curable Formulation Estimates and Forecasts (2016-2027)
    • 1.5.5 China Radiation Curable Formulation Estimates and Forecasts (2016-2027)
    • 1.5.5 Japan Radiation Curable Formulation Estimates and Forecasts (2016-2027)

2 Market Competition by Manufacturers

  • 2.1 Global Radiation Curable Formulation Production Capacity Market Share by Manufacturers (2016-2021)
  • 2.2 Global Radiation Curable Formulation Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Radiation Curable Formulation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.4 Global Radiation Curable Formulation Average Price by Manufacturers (2016-2021)
  • 2.5 Manufacturers Radiation Curable Formulation Production Sites, Area Served, Product Types
  • 2.6 Radiation Curable Formulation Market Competitive Situation and Trends
    • 2.6.1 Radiation Curable Formulation Market Concentration Rate
    • 2.6.2 Global 5 and 10 Largest Radiation Curable Formulation Players Market Share by Revenue
    • 2.6.3 Mergers & Acquisitions, Expansion

3 Production and Capacity by Region

  • 3.1 Global Production Capacity of Radiation Curable Formulation Market Share by Region (2016-2021)
  • 3.2 Global Radiation Curable Formulation Revenue Market Share by Region (2016-2021)
  • 3.3 Global Radiation Curable Formulation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 3.4 North America Radiation Curable Formulation Production
    • 3.4.1 North America Radiation Curable Formulation Production Growth Rate (2016-2021)
    • 3.4.2 North America Radiation Curable Formulation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 3.5 Europe Radiation Curable Formulation Production
    • 3.5.1 Europe Radiation Curable Formulation Production Growth Rate (2016-2021)
    • 3.5.2 Europe Radiation Curable Formulation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 3.6 China Radiation Curable Formulation Production
    • 3.6.1 China Radiation Curable Formulation Production Growth Rate (2016-2021)
    • 3.6.2 China Radiation Curable Formulation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 3.7 Japan Radiation Curable Formulation Production
    • 3.7.1 Japan Radiation Curable Formulation Production Growth Rate (2016-2021)
    • 3.7.2 Japan Radiation Curable Formulation Production Capacity, Revenue, Price and Gross Margin (2016-2021)

4 Global Radiation Curable Formulation Consumption by Region

  • 4.1 Global Radiation Curable Formulation Consumption by Region
    • 4.1.1 Global Radiation Curable Formulation Consumption by Region
    • 4.1.2 Global Radiation Curable Formulation Consumption Market Share by Region
  • 4.2 North America
    • 4.2.1 North America Radiation Curable Formulation Consumption by Country
    • 4.2.2 U.S.
    • 4.2.3 Canada
  • 4.3 Europe
    • 4.3.1 Europe Radiation Curable Formulation Consumption by Country
    • 4.3.2 Germany
    • 4.3.3 France
    • 4.3.4 U.K.
    • 4.3.5 Italy
    • 4.3.6 Russia
  • 4.4 Asia Pacific
    • 4.4.1 Asia Pacific Radiation Curable Formulation Consumption by Region
    • 4.4.2 China
    • 4.4.3 Japan
    • 4.4.4 South Korea
    • 4.4.5 Taiwan
    • 4.4.6 Southeast Asia
    • 4.4.7 India
    • 4.4.8 Australia
  • 4.5 Latin America
    • 4.5.1 Latin America Radiation Curable Formulation Consumption by Country
    • 4.5.2 Mexico
    • 4.5.3 Brazil

5 Production, Revenue, Price Trend by Type

  • 5.1 Global Radiation Curable Formulation Production Market Share by Type (2016-2021)
  • 5.2 Global Radiation Curable Formulation Revenue Market Share by Type (2016-2021)
  • 5.3 Global Radiation Curable Formulation Price by Type (2016-2021)

6 Consumption Analysis by Application

  • 6.1 Global Radiation Curable Formulation Consumption Market Share by Application (2016-2021)
  • 6.2 Global Radiation Curable Formulation Consumption Growth Rate by Application (2016-2021)

7 Key Companies Profiled

  • 7.1 BASF SE
    • 7.1.1 BASF SE Radiation Curable Formulation Corporation Information
    • 7.1.2 BASF SE Radiation Curable Formulation Product Portfolio
    • 7.1.3 BASF SE Radiation Curable Formulation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.1.4 BASF SE Main Business and Markets Served
    • 7.1.5 BASF SE Recent Developments/Updates
  • 7.2 DIC
    • 7.2.1 DIC Radiation Curable Formulation Corporation Information
    • 7.2.2 DIC Radiation Curable Formulation Product Portfolio
    • 7.2.3 DIC Radiation Curable Formulation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.2.4 DIC Main Business and Markets Served
    • 7.2.5 DIC Recent Developments/Updates
  • 7.3 Arkema (Sartomer)
    • 7.3.1 Arkema (Sartomer) Radiation Curable Formulation Corporation Information
    • 7.3.2 Arkema (Sartomer) Radiation Curable Formulation Product Portfolio
    • 7.3.3 Arkema (Sartomer) Radiation Curable Formulation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.3.4 Arkema (Sartomer) Main Business and Markets Served
    • 7.3.5 Arkema (Sartomer) Recent Developments/Updates
  • 7.4 Cytec (Solvay S.A.)
    • 7.4.1 Cytec (Solvay S.A.) Radiation Curable Formulation Corporation Information
    • 7.4.2 Cytec (Solvay S.A.) Radiation Curable Formulation Product Portfolio
    • 7.4.3 Cytec (Solvay S.A.) Radiation Curable Formulation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.4.4 Cytec (Solvay S.A.) Main Business and Markets Served
    • 7.4.5 Cytec (Solvay S.A.) Recent Developments/Updates
  • 7.5 DuPont
    • 7.5.1 DuPont Radiation Curable Formulation Corporation Information
    • 7.5.2 DuPont Radiation Curable Formulation Product Portfolio
    • 7.5.3 DuPont Radiation Curable Formulation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.5.4 DuPont Main Business and Markets Served
    • 7.5.5 DuPont Recent Developments/Updates
  • 7.6 Royal DSM
    • 7.6.1 Royal DSM Radiation Curable Formulation Corporation Information
    • 7.6.2 Royal DSM Radiation Curable Formulation Product Portfolio
    • 7.6.3 Royal DSM Radiation Curable Formulation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.6.4 Royal DSM Main Business and Markets Served
    • 7.6.5 Royal DSM Recent Developments/Updates
  • 7.7 IGM Resins
    • 7.7.1 IGM Resins Radiation Curable Formulation Corporation Information
    • 7.7.2 IGM Resins Radiation Curable Formulation Product Portfolio
    • 7.7.3 IGM Resins Radiation Curable Formulation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.7.4 IGM Resins Main Business and Markets Served
    • 7.7.5 IGM Resins Recent Developments/Updates
  • 7.8 Allnex
    • 7.8.1 Allnex Radiation Curable Formulation Corporation Information
    • 7.8.2 Allnex Radiation Curable Formulation Product Portfolio
    • 7.8.3 Allnex Radiation Curable Formulation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.8.4 Allnex Main Business and Markets Served
    • 7.7.5 Allnex Recent Developments/Updates
  • 7.9 Chongqing Changfeng Chemical
    • 7.9.1 Chongqing Changfeng Chemical Radiation Curable Formulation Corporation Information
    • 7.9.2 Chongqing Changfeng Chemical Radiation Curable Formulation Product Portfolio
    • 7.9.3 Chongqing Changfeng Chemical Radiation Curable Formulation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.9.4 Chongqing Changfeng Chemical Main Business and Markets Served
    • 7.9.5 Chongqing Changfeng Chemical Recent Developments/Updates
  • 7.10 Eternal Materials
    • 7.10.1 Eternal Materials Radiation Curable Formulation Corporation Information
    • 7.10.2 Eternal Materials Radiation Curable Formulation Product Portfolio
    • 7.10.3 Eternal Materials Radiation Curable Formulation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.10.4 Eternal Materials Main Business and Markets Served
    • 7.10.5 Eternal Materials Recent Developments/Updates
  • 7.11 Miwon Specialty Chemical
    • 7.11.1 Miwon Specialty Chemical Radiation Curable Formulation Corporation Information
    • 7.11.2 Miwon Specialty Chemical Radiation Curable Formulation Product Portfolio
    • 7.11.3 Miwon Specialty Chemical Radiation Curable Formulation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.11.4 Miwon Specialty Chemical Main Business and Markets Served
    • 7.11.5 Miwon Specialty Chemical Recent Developments/Updates
  • 7.12 Jiangsu Sanmu Group
    • 7.12.1 Jiangsu Sanmu Group Radiation Curable Formulation Corporation Information
    • 7.12.2 Jiangsu Sanmu Group Radiation Curable Formulation Product Portfolio
    • 7.12.3 Jiangsu Sanmu Group Radiation Curable Formulation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.12.4 Jiangsu Sanmu Group Main Business and Markets Served
    • 7.12.5 Jiangsu Sanmu Group Recent Developments/Updates
  • 7.13 PPG
    • 7.13.1 PPG Radiation Curable Formulation Corporation Information
    • 7.13.2 PPG Radiation Curable Formulation Product Portfolio
    • 7.13.3 PPG Radiation Curable Formulation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.13.4 PPG Main Business and Markets Served
    • 7.13.5 PPG Recent Developments/Updates
  • 7.14 T&K TOKA
    • 7.14.1 T&K TOKA Radiation Curable Formulation Corporation Information
    • 7.14.2 T&K TOKA Radiation Curable Formulation Product Portfolio
    • 7.14.3 T&K TOKA Radiation Curable Formulation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.14.4 T&K TOKA Main Business and Markets Served
    • 7.14.5 T&K TOKA Recent Developments/Updates
  • 7.15 Heygey
    • 7.15.1 Heygey Radiation Curable Formulation Corporation Information
    • 7.15.2 Heygey Radiation Curable Formulation Product Portfolio
    • 7.15.3 Heygey Radiation Curable Formulation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.15.4 Heygey Main Business and Markets Served
    • 7.15.5 Heygey Recent Developments/Updates
  • 7.16 Suzhou Mingda
    • 7.16.1 Suzhou Mingda Radiation Curable Formulation Corporation Information
    • 7.16.2 Suzhou Mingda Radiation Curable Formulation Product Portfolio
    • 7.16.3 Suzhou Mingda Radiation Curable Formulation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.16.4 Suzhou Mingda Main Business and Markets Served
    • 7.16.5 Suzhou Mingda Recent Developments/Updates
  • 7.17 Himonia
    • 7.17.1 Himonia Radiation Curable Formulation Corporation Information
    • 7.17.2 Himonia Radiation Curable Formulation Product Portfolio
    • 7.17.3 Himonia Radiation Curable Formulation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.17.4 Himonia Main Business and Markets Served
    • 7.17.5 Himonia Recent Developments/Updates
  • 7.18 Tianjin Jiuri New
    • 7.18.1 Tianjin Jiuri New Radiation Curable Formulation Corporation Information
    • 7.18.2 Tianjin Jiuri New Radiation Curable Formulation Product Portfolio
    • 7.18.3 Tianjin Jiuri New Radiation Curable Formulation Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.18.4 Tianjin Jiuri New Main Business and Markets Served
    • 7.18.5 Tianjin Jiuri New Recent Developments/Updates

8 Radiation Curable Formulation Manufacturing Cost Analysis

  • 8.1 Radiation Curable Formulation Key Raw Materials Analysis
    • 8.1.1 Key Raw Materials
    • 8.1.2 Key Raw Materials Price Trend
    • 8.1.3 Key Suppliers of Raw Materials
  • 8.2 Proportion of Manufacturing Cost Structure
  • 8.3 Manufacturing Process Analysis of Radiation Curable Formulation
  • 8.4 Radiation Curable Formulation Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

  • 9.1 Marketing Channel
  • 9.2 Radiation Curable Formulation Distributors List
  • 9.3 Radiation Curable Formulation Customers

10 Market Dynamics

  • 10.1 Radiation Curable Formulation Industry Trends
  • 10.2 Radiation Curable Formulation Growth Drivers
  • 10.3 Radiation Curable Formulation Market Challenges
  • 10.4 Radiation Curable Formulation Market Restraints

11 Production and Supply Forecast

  • 11.1 Global Forecasted Production of Radiation Curable Formulation by Region (2022-2027)
  • 11.2 North America Radiation Curable Formulation Production, Revenue Forecast (2022-2027)
  • 11.3 Europe Radiation Curable Formulation Production, Revenue Forecast (2022-2027)
  • 11.4 China Radiation Curable Formulation Production, Revenue Forecast (2022-2027)
  • 11.5 Japan Radiation Curable Formulation Production, Revenue Forecast (2022-2027)

12 Consumption and Demand Forecast

  • 12.1 Global Forecasted Demand Analysis of Radiation Curable Formulation
  • 12.2 North America Forecasted Consumption of Radiation Curable Formulation by Country
  • 12.3 Europe Market Forecasted Consumption of Radiation Curable Formulation by Country
  • 12.4 Asia Pacific Market Forecasted Consumption of Radiation Curable Formulation by Region
  • 12.5 Latin America Forecasted Consumption of Radiation Curable Formulation by Country

13 Forecast by Type and by Application (2022-2027)

  • 13.1 Global Production, Revenue and Price Forecast by Type (2022-2027)
    • 13.1.1 Global Forecasted Production of Radiation Curable Formulation by Type (2022-2027)
    • 13.1.2 Global Forecasted Revenue of Radiation Curable Formulation by Type (2022-2027)
    • 13.1.3 Global Forecasted Price of Radiation Curable Formulation by Type (2022-2027)
  • 13.2 Global Forecasted Consumption of Radiation Curable Formulation by Application (2022-2027)

14 Research Finding and Conclusion

    15 Methodology and Data Source

    • 15.1 Methodology/Research Approach
      • 15.1.1 Research Programs/Design
      • 15.1.2 Market Size Estimation
      • 15.1.3 Market Breakdown and Data Triangulation
    • 15.2 Data Source
      • 15.2.1 Secondary Sources
      • 15.2.2 Primary Sources
    • 15.3 Author List

    The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2016 to 2027. by Application segment also provides consumption during the forecast period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Ultraviolet (UV) Curing
    Electron beam (EB) Curing

    Segment by Application
    Coatings
    Inks
    Adhesives
    Electronics

    By Company
    BASF SE
    DIC
    Arkema (Sartomer)
    Cytec (Solvay S.A.)
    DuPont
    Royal DSM
    IGM Resins
    Allnex
    Chongqing Changfeng Chemical
    Eternal Materials
    Miwon Specialty Chemical
    Jiangsu Sanmu Group
    PPG
    T&K TOKA
    Heygey
    Suzhou Mingda
    Himonia
    Tianjin Jiuri New

    Production by Region
    North America
    Europe
    China
    Japan

    Consumption by Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    Buy now